Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Current Assets (2017 - 2025)

Catheter Precision (VTAK) has disclosed Current Assets for 9 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets rose 43.93% to $2.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.5 million, a 43.93% increase, with the full-year FY2024 number at $3.3 million, down 20.88% from a year prior.
  • Current Assets was $2.5 million for Q3 2025 at Catheter Precision, up from $2.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $24.1 million in Q2 2021 to a low of $388000.0 in Q2 2024.
  • A 5-year average of $10.0 million and a median of $6.8 million in 2023 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: plummeted 95.09% in 2024, then skyrocketed 427.32% in 2025.
  • Catheter Precision's Current Assets stood at $17.1 million in 2021, then decreased by 1.48% to $16.8 million in 2022, then plummeted by 75.29% to $4.2 million in 2023, then fell by 20.88% to $3.3 million in 2024, then decreased by 25.06% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Current Assets are $2.5 million (Q3 2025), $2.0 million (Q2 2025), and $854000.0 (Q1 2025).